CrushSCI.com
Journal Selection & Manuscript Polishing Services
MEDICINAL RESEARCH REVIEWS journal cover Medicine
Back to journal directory

Review Cycle Records

MEDICINAL RESEARCH REVIEWS

Wiley SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
148.9Average days
144.5Median days
104Fastest days
198Longest days
652025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

121 days

Insights From Spatiality: Accelerating Pharmaceutical Research Using Mass Spectrometry Imaging

AuthorsYuchen Zou; Zhiye Yan; Weiwei Tang; Bin Li

Affiliations1. State Key Laboratory of Natural Medicines and School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing China

Source PDF DOI Publisher page
144 days

Exercise‐Induced Exerkines: Multi‐Nodal Suppression of the NLRP3 Inflammasome and Translational Potential

AuthorsHuaiming Wang; Zongqiang Jin; Shijing Di; Hamid Alizadeh

Affiliations1. School of Sports Training Tianjin University of Sport Tianjin China; 2. School of Physical Education Tianjin University of Sport Tianjin China; 3. Division of Exercise Physiology and Metabolism, Faculty of Sports Sciences The University of Mazandaran Babolsar Mazandaran Iran

Source PDF DOI Publisher page
155 days

Targeting ClpP Protease: Emerging Therapeutic Strategies and Small‐Molecule Modulators in Drug Discovery

AuthorsLihua Liu; Minghui Yu; Xinnan Li; Jinyi Xu; Shaowen Xie; Shengtao Xu; Hong Yao

Affiliations1. Department of Medicinal Chemistry, School of Pharmacy China Pharmaceutical University Nanjing Jiangsu China

Source PDF DOI Publisher page
184 days

Quantification of 10 B and 11 B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT)

AuthorsChristoph Selg; Wolfgang A. G. Sauerwein; Evamarie Hey‐Hawkins

Affiliations1. Centre for Biotechnology and Biomedicine (BBZ), Institute of Bioanalytical Chemistry, Faculty of Chemistry Leipzig University Leipzig Germany; 2. Department for Radiation Oncology, Deutsche Gesellschaft für Bor‐Neutroneneinfangtherapie e. V. (DGBNCT) University Hospital Essen Essen Germany; 3. Department of Chemistry Babeș‐Bolyai University Cluj‐Napoca Romania

Source PDF DOI Publisher page
104 days

STING: An Attractive Target for Autoimmune and Inflammatory Diseases

AuthorsZhenjiao Yang; Xinqiao Liu; Jinhong Zhan; Mingliang Ma; Yuanxiang Wang

Affiliations1. Balance‐Based Drug Discovery Laboratory, School of Pharmaceutical Sciences Sun Yat‐Sen University Guangzhou China; 2. Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering East China Normal University Shanghai China; 3. NHC Key Laboratory of Nuclear Technology Medical Transformation (MIANYANG CENTRAL HOSPITAL) Mianyang China

Source PDF DOI Publisher page
131 days

Decoding WDR5‐Mediated Interactions in Gliomas: Implications for Targeted Therapy

AuthorsEdmund Jung; Christina Piperi

Affiliations1. Department of Biological Chemistry, Medical School National and Kapodistrian University of Athens Athens Greece

Source PDF DOI Publisher page
173 days

Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000–2025)

AuthorsAhmed A. Al‐Karmalawy; Abdullah Al‐Dakhil; Nada A. Ashour; Tarek A. Yousef; Samar S. Mabrouk; Arwa Omar Al Khatib; Samia S. Hawas

Affiliations1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Horus University‐Egypt New Damietta Egypt; 2. College of Science, Chemistry Department Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh Saudi Arabia; 3. Department of Pharmacology and Toxicology, Faculty of Pharmacy Mansoura National University Gamasa Egypt; 4. Department of Microbiology, Faculty of Pharmacy Ahram Canadian University (ACU) 6th October City, Giza Egypt; 5. Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan

Source PDF DOI Publisher page
145 days

Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery

AuthorsJun‐Jie Wang; Ya Gao; Xin‐Qian Ji; Jia‐Yi Yin; Meng‐Zhi Zhang; Bo Wang; Hui‐Min Liu; Siqi Feng; Ning Wang; Guo‐Liang Lu; Yan Li; Piet Herdewijn; Yi‐Chao Zheng; Peng Yan; Xing‐Jie Dai

Affiliations1. State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Key Laboratory of Henan Province for Small Molecule Drug Discovery and Application, School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China; 2. School of Chinese Medicine University of Hong Kong Hong Kong; 3. Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand; 4. Maurice Wilkins Centre The University of Auckland Auckland New Zealand; 5. Department of Biomedicine and Medical Diagnostics, School of Science Auckland University of Technology Auckland New Zealand; 6. XNA Platform, School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China; 7. Rega Institute for Medical Research, Medicinal Chemistry KU Leuven Leuven Belgium; 8. Orthopedic Ward 3, The Fifth Affiliated Hospital of Zhengzhou University Zhengzhou China

Source PDF DOI Publisher page
134 days

Advances in SIRT2‐Targeted Therapeutics: Structural Insights, Chemical Strategies, and Degrader Technologies

AuthorsAhmed A. Al‐Karmalawy; Wolfgang Sippl; Abdullah Al‐Dakhil; Tarek A. Yousef; Arwa Omar Al Khatib; Samia S. Hawas

Affiliations1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Horus University‐Egypt New Damietta Egypt; 2. Department of Medicinal Chemistry, Institute of Pharmacy Martin‐Luther‐University of Halle‐Wittenberg Halle Germany; 3. College of Science, Chemistry Department Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh Saudi Arabia; 4. Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan

Source PDF DOI Publisher page
198 days

Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns

AuthorsAmandeep Thakur; Mandeep Rana; Sakshi Vanjani; Kei‐Chi Liou; Rajeev Taliyan; Kunal Nepali; Chih‐Hao Yang

Affiliations1. School of Pharmacy, College of Pharmacy Taipei Medical University Taipei Taiwan; 2. Molecular Medicine University of South Florida Tampa Florida USA; 3. Department of Pharmacy Birla Institute of Technology & Science Pilani Rajasthan India; 4. Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy Taipei Medical University Taipei Taiwan; 5. Department of Pharmacology, School of Medicine, College of Medicine Taipei Medical University Taipei Taiwan; 6. Research Center for Neuroscience Taipei Medical University Taipei Taiwan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.